# Comparison of Orcinoside With Placebo in Treatment of MDD

> **NCT02191384** · PHASE2 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 186 (actual)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **DRUG:** Orcinoside

## Key facts

- **NCT ID:** NCT02191384
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-03-09
- **Final completion:** 2016-03-09
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2021-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191384, "Comparison of Orcinoside With Placebo in Treatment of MDD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02191384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*